DiJing Yu

DiJing Yu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
QBQingqing Bai
Qingqing Bai
SWShuoyang Wang
Shuoyang Wang
DRDongmei Rao
Dongmei Rao
ZZZhiming Zhou
Zhiming Zhou
JWJianfei Wang
Jianfei Wang
YXYang xu
Yang xu
Background: Necroptosis induced by receptor‐interacting protein kinase 3 (RIPK3) is engaged in intracerebral hemorrhage (ICH) pathology. In this study, we explored the impact of RIPK3 activation on neuronal necroptosis and the mechanism of the death domain‐associated protein (DAXX)‐mediated nuclear necroptosis pathway after ICH.Methods: Potential molecules linked to the progression of ICH were discovered using RNA sequencing. The level of DAXX was assessed by quantitative real‐time PCR, ELISA, and western blotting. DAXX localization was determined by immunofluorescence and immunoprecipitation assays. The RIPK3 inhibitor GSK872 and DAXX knockdown with shRNA‐DAXX were used to examine the nuclear necroptosis pathway associated with ICH. Neurobehavioral deficit assessments were performed.Results: DAXX was increased in patients and mice after ICH. In an ICH mouse model, shRNA‐DAXX reduced brain water content and alleviated neurologic impairments. GSK872 administration reduced the expression of DAXX. shRNA‐DAXX inhibited the expression of p‐MLKL. Immunofluorescence and immunoprecipitation assays showed that RIPK3 and AIF translocated into the nucleus and then bound with nuclear DAXX.Conclusions: RIPK3 revitalization promoted neuronal necroptosis in ICH mice, partially through the DAXX signaling pathway. RIPK3 and AIF interacted with nuclear DAXX to aggravate ICH injury.

1 April 2021 in Neuroscience Letters
Verified
Journal Article
Closed access
YXYang Xu
Yang Xu
XWXiaodong Wu
Xiaodong Wu
WHWenjie Hu
Wenjie Hu
DYDiJing Yu
DiJing Yu
ZSZhiding Shao
Zhiding Shao
LKLv Kun
Lv Kun